Masimo Corporation (MASI)

Market Cap	7.68B
Revenue (ttm)	2.15B
Net Income (ttm)	-459.20M
Shares Out	54.32M
EPS (ttm)	-8.54
PE Ratio	n/a
Forward PE	25.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	652,513
Open	140.19
Previous Close	139.75
Day's Range	139.60 - 142.81
52-Week Range	131.01 - 194.88
Beta	1.23
Analysts	Buy
Price Target	194.60 (+37.55%)
Earnings Date	Nov 4, 2025

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Summary

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price target is $194.6, which is an increase of 37.55% from the latest price.

Price Target

$194.6

(37.55% upside)

Analyst Consensus: Buy